Tarsus Pharmaceuticals, Inc.

Q4 2023 13F Holders

Symbol: TARS
CUSIP: 87650L103
Type: Equity
Class: COM
Num filings: 126
Total reported value, excl. options: $705 M

Compare 2023 Q4 to

Manager	Report Date	Value ($000)	Shares	Option Type